SCHEMBL8636838

SCHEMBL8636838

NS(=O)(=O)c1ccccc1-n1nc(C(F)F)cc1-c1cccs1

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.46
PTGS1 P23219 9/20 0.46
CA1 P00915 5/20 0.37
CA2 P00918 5/20 0.37
CA9 Q16790 5/20 0.37
CA12 O43570 1/20 0.36
ABCB11 O95342 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8691340 0.84 PTGS2 (0.44) PTGS2PTGS1CA1CA2CA9
SCHEMBL8638755 0.82 PTGS2 (0.46) PTGS2PTGS1CA2
SCHEMBL8636811 0.82 PTGS2 (0.46) PTGS2PTGS1CA1CA2CA9
SCHEMBL7928751 0.82 PTGS2 (0.66) PTGS2PTGS1ABCB11ALDH1A1
SCHEMBL8638930 0.82 PTGS2 (0.46) PTGS2PTGS1ALDH1A1
SCHEMBL6341875 0.81 PTGS2 (0.67) PTGS2PTGS1CA1CA2CA9
SCHEMBL9080132 0.80 PTGS2 (0.63) PTGS2PTGS1CA1CA2CA9
SCHEMBL8637047 0.80 PTGS2 (0.63) PTGS2PTGS1CA1CA2CA9
SCHEMBL8639180 0.79 PTGS2 (0.53) PTGS2PTGS1ABCB11ALDH1A1
SCHEMBL8688520 0.78 PTGS2 (0.43) PTGS2PTGS1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760068-A NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G.D. SEARLE & CO. (US) 1998-06-02 US disclosed
US-5756529-A ANTIINFLAMMATORY G.D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5753688-A ANTIINFLAMMATORY TALLEY JOHN J (US) 1998-05-19 US disclosed
US-5510496-A ANTIINFLAMMATORY AGENTS G.D. SEARLE & CO. (US) 1996-04-23 US disclosed
US-5504215-A Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-04-02 US disclosed